Local Health Officials to Feds: Where’s the Rest of Our Monkeypox Vaccine?
Los Angeles County is getting 60% fewer doses of monkeypox vaccine than officials expected, after the FDA said every vial could be split into five shots.
CDC
201 - 220 of 554 Results
-
-
Covid Sewage Surveillance Labs Join the Hunt for Monkeypox
Wastewater testing has proved a reliable early alarm bell for covid outbreaks. U.S. researchers are now adapting the approach to track the explosive spread of monkeypox.
-
Cognitive Rehab May Help Older Adults Clear Covid-Related Brain Fog
People whose brains have been injured by concussions, traumatic accidents, strokes, or neurodegenerative conditions such as Parkinson’s disease can benefit from targeted therapy. Experts also employ therapies for long-covid patients with memory and language problems.
-
Skin Cancer Is a Risk No Matter the Skin Tone. But It May Be Overlooked in People With Dark Skin.
Black people and those with high levels of melanin in their skin have long been left out of efforts to combat skin cancer. Historically neglected both by sunscreen manufacturers and a medical community lagging in diversity and cultural competency, many people with dark skin tones have not been informed about sun safety or how to monitor their skin for damage or cancer.
By Sandy West -
What the Polio Case in New York Tells Us About the End of Polio
The Rockland County case isn’t expected to cause a major outbreak, but it shows how even this rare disease can pop up in undervaccinated communities.
By Arthur Allen -
Perspective
To Stem the Spread of Monkeypox, Health Departments Tap Into Networks of Those Most at Risk
Although the disease is currently spreading almost exclusively among men who have sex with men, some cases are turning up in other populations — and that number is likely to grow if public health officials don’t effectively nip the outbreak in the bud.
-
-
Critics Worry Government Surveillance of HIV May Hurt More Than It Helps
Some people living with HIV and some state health officials are raising concerns about part of the federal effort to end the HIV epidemic: a new technology that analyzes blood samples to find emerging outbreaks. The critics say it’s too invasive and stigmatizing and might not be more effective than older public health approaches.
-
Boost Now or Wait? Many Wonder How Best to Ride Out Covid’s Next Wave
As the country faces a rise in new infections driven by the omicron BA.5 subvariant of the coronavirus, about 70% of people 50 and older who got a first covid-19 booster shot haven't received the recommended second one, according to the Centers for Disease Control and Prevention. Many undervaccinated Americans have lost interest, and others aren’t sure whether to get boosted again now or wait for vaccines reformulated to target newer strains of the virus.
By Sam Whitehead and Arthur Allen -
A Free-for-All From Readers and Tweeters, From Medical Debt to Homelessness
KHN gives readers a chance to comment on a recent batch of stories.
-
Hospital-Acquired Pneumonia Is Killing Patients. Yet There Is a Simple Way to Stop It.
Hospital-acquired pneumonia not tied to ventilators is one of the most common infections that strike within health care facilities. But few hospitals take steps to prevent it, which can be as simple as dutifully brushing patients’ teeth.
By Brett Kelman -
Vaccine and Testing Delays for Monkeypox Echo Failures in Early Covid Response
Public health officials say monkeypox is not as dangerous as covid and can be handled well with current treatments and if those at risk use caution. But the rollout of vaccines has been slow and led to angst among some at-risk people.
-
Feds Want a Policy That Advocates Say Would Let Hospitals Off the Hook for Covid-Era Lapses
The pandemic disrupted all sense of normalcy for U.S. hospitals, so federal officials are proposing to pause financial penalties against the facilities and to block public access to key hospital safety data — such as the frequency of falls and sepsis — because of concerns that the data isn’t accurate enough. But consumer advocates are furious about the proposal.
By Lauren Weber -
How Pfizer Won the Pandemic, Reaping Outsize Profit and Influence
The drugmaker has the best-selling vaccine to prevent covid and the most effective drug to treat it. Its success has overshadowed the government’s covid-fighting strategy.
By Arthur Allen -
Montana’s Blackfeet Tribe to Use Dogs to Sniff Out Disease and Contaminants
The Blackfeet Nation is experimenting with a new way to detect chronic wasting disease in animals used by tribal members for food and cultural practices.
-
What You Need to Know About Monkeypox
For now, monkeypox poses a low risk to the U.S. public, but it could become a problem if the spread is left unchecked. Here’s what everyone should know about it.
-
Readers and Tweeters Weigh In on Medical Debt, the Obesity Epidemic, and Opioid Battles
KHN gives readers a chance to comment on a recent batch of stories.
-
Perspective
Will the US Overcome Its Covid Complacency Even as the Threat Returns?
One million Americans have died from covid-19 — far more per capita than in any other developed country. A new variant is doubling case rates in some states, and more than 300 people are dying a day. But our nation’s pandemic response has become mild-mannered and performative, backed by neither money, urgency, nor enforcement.
-
Covid Funding Pries Open a Door to Improving Air Quality in Schools
Researchers say the billions in pandemic funding available for ventilation upgrades in U.S. schools provides a once-in-a-generation opportunity to combat covid-19, as well as making air more breathable for students living with allergies, asthma, and chronic wildfire smoke.
By Liz Szabo -
Grassroots Groups Lead Way on Closing Colorado’s Infant Mortality Gap
Colorado is among about 15 states that have met federal goals to reduce infant mortality, an important indicator of overall population health. Breaking down the data by race and ethnicity, though, makes clear that major gaps remain.